Tatva Chintan Pharma Chem Limited

TATVA.NS·NSE·Basic Materials
Compare
1,903.40−40.60 (−2.09%)today
At close: Oct 19, 3:29 PM IST · May be delayed up to 15 min · INR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1,944.00
Open1,944.00
Day range1,847.501,992.90
52-week range1,044.102,008.70
Off day high−4.49%
Off 52-week high−5.24%
Volume143.47K
Avg. volume (3M)114.40K
Market cap44.52B
EPS (TTM)26.90
Forward P/E46.46
P/E ratio (TTM)70.76
Dividend yield0.11% (2.00)
Beta (5Y)0.30
Shares outstanding23.39M
Short interest—
Earnings dateMay 2, 2025
Analyst target1,550.00
Profit margin9.24%

Against its peers

Compare in full ›
TATVA.NS 002709.SZ CLEAN.NS VINATIORGA.BO ACUTAAS.NS 002643.SZ
Market cap 44.52B 57.26B 80.76B 115.82B 266.36B 10.59B
P/E (TTM) 70.8 14.2 34.7 25.8 69.2 42.8
Forward P/E 46.5 7.7 23.8 20.5 44.4 21.0
Price/book 5.7 2.8 5.1 3.7 16.1 1.5
Dividend yield 0.11% 0.54% 0.79% 0.76% 0.08% 1.10%
1-year change +35.27% −20.23% −27.85% −34.01% +81.90% −10.82%
Today −2.09% +0.64% −3.06% −1.52% +1.48% +1.67%

The closest companies by business and industry (Specialty Chemicals). Prices may be delayed up to 15 min.

Latest news

All TATVA.NS news ›
TechGraph·Negative

Tatva Chintan Pharma Chem (TATVA) Share Price, NSE | TechGraph

Tatva Chintan Pharma Chem Limited (TATVA) share price and stock price today is ₹1,804.80, -2.74% for the session. Live NSE quote and chart. Analyst figures are shown only when the research feed provides them. Company profile is sourced…

From articles in the 4Search news index.

In the news

2mentions in 30 days
2with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.